RH
ABBV icon

Rayner & Haynor’s AbbVie ABBV Stock Holding History

Rayner & Haynor’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$796K Sell
13,775
-450
-3% -$25K 0.61% 46
2014
Q2 		$803K Sell
14,225
-600
-4% -$31.5K 0.61% 46
2014
Q1 		$762K Sell
14,825
-550
-4% -$27.8K 0.6% 47
2013
Q4 		$812K Buy
+15,375
New +$756K 0.63% 46

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Rayner & Haynor's ABBV Position: Q3 2014 in Review

Rayner & Haynor reduced its AbbVie (ABBV) stake by 3.2% in Q3 2014, selling an estimated $25K and leaving 13,775 shares worth $796K. The position accounts for 0.61% of the portfolio, ranked #46.

Rayner & Haynor first reported a position in ABBV in Q4 2013 and has held it in 4 quarters since. The position peaked at $812K in Q4 2013. 1,501 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

  • Rayner & Haynor held 13,775 shares of AbbVie worth $796K as of Q3 2014.
  • Rayner & Haynor sold 450 AbbVie shares in Q3 2014, an estimated $25K.
  • AbbVie made up 0.61% of Rayner & Haynor's portfolio in Q3 2014, its #46 holding.
  • Rayner & Haynor first reported a position in AbbVie in Q4 2013 and has held it in 4 quarters since.
  • Rayner & Haynor's AbbVie position peaked at $812K in Q4 2013.
  • 1,501 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Rayner & Haynor's 13F filing for Q3 2014, filed 14 Nov 2014.